|
|
Post by peppy on Sept 20, 2021 8:52:09 GMT -5
It may come down to this. The Pandemic is't getting better and the season of the year is fall.
Humanity might need to have the ability to get a amino acid /chemical medication down to the Alveoli.
That may be the ticket.
I think it would be funny if MNKD goes positive here.
23 mins out summary volume, 407,644
4.5200-0.0100 (-0.2208%)
As of 9:54AM EDT. Market open.
|
|
|
|
Post by peppy on Sept 20, 2021 8:57:03 GMT -5
one more thing, I would really see the humor if MNKD broke up and out today.
4.5778+0.0478 (+1.0552%)
433,168
Avg. Volume 2,950,038
I may be going too far.
|
|
|
|
Post by peppy on Sept 20, 2021 9:30:30 GMT -5
MNKD Nasdaq volume at 1 hour of trade.
real time, 366,573
summary, 547,980
Avg. Volume 2,950,038
4.5299. -0.0001 (-0.00%)
As of 10:29AM EDT. Market open.
added, MNKD volume at two hours of trade,
real time, 443,975
summary, 703,749
4.5200-0.0100 (-0.2208%)
As of 11:29AM EDT. Market open.
|
|
|
|
Post by peppy on Sept 20, 2021 11:46:33 GMT -5
MNKD Nasdaq volume at 1 hour of trade. real time, 366,573 summary, 547,980 Avg. Volume 2,950,038 4.5299. -0.0001 (-0.00%) As of 10:29AM EDT. Market open. added, MNKD volume at two hours of trade, real time, 443,975 summary, 703,749 4.5200-0.0100 (-0.2208%) As of 11:29AM EDT. Market open. www.nasdaq.com/market-activity/stocks/mnkd/real-timefinance.yahoo.com/quote/MNKD?p=MNKDMNKD volume at the half day of trade. real time, 565,626 Summary, 892,189  How many days in your life do you see the SPX down 90 points? |
|
|
|
Post by joeypotsandpans on Sept 20, 2021 12:59:26 GMT -5
Monthly low for Aug was 3.76 while the monthly high was 4.97, we've already notched a higher high on the monthly chart so I'm liking the odds here for a decent close for Sep., regardless of what the broader market is doing 😉
|
|
|
|
Post by peppy on Sept 20, 2021 15:09:54 GMT -5
MNKD Nasdaq volume at 1 hour of trade. real time, 366,573 summary, 547,980 Avg. Volume 2,950,038 4.5299. -0.0001 (-0.00%) As of 10:29AM EDT. Market open. added, MNKD volume at two hours of trade, real time, 443,975 summary, 703,749 4.5200-0.0100 (-0.2208%) As of 11:29AM EDT. Market open. www.nasdaq.com/market-activity/stocks/mnkd/real-timefinance.yahoo.com/quote/MNKD?p=MNKDMNKD volume at the half day of trade. real time, 565,626 Summary, 892,189 $4.51 -.02 MNKD Nasdaq real time volume, 1,650,625 shares. (700,000 shares came in at the end of the day.) MNKD Nasdaq summary volume, 2,302,473 4.4800. -0.0500 (-1.1038%) At close: 4:00PM EDT MNKD daily chart, this triangle... the coil is getting tighter....  I am going to post some market charts off topic under change of trend. |
|
|
|
Post by sweedee79 on Sept 20, 2021 18:39:46 GMT -5
I'm waiting for the charts... Hopefully something optimistic.. I'm needing it right now..
|
|
|
|
Post by cjc04 on Sept 20, 2021 18:48:00 GMT -5
I'm waiting for the charts... Hopefully something optimistic.. I'm needing it right now.. I could use something optimistic too... I was afraid they’d find a way to drag it down to the $4.50 PUTS this past Friday, but that’s not what really worries me. November PUTS are really scary, and they always seem to find a way. |
|
|
|
Post by stockwhisperer on Sept 20, 2021 19:47:31 GMT -5
It’s all riding on the FDA‘s decision sometime between now and the end of Oct. I am still thinking Oct 15 at the latest but just my guess. If it is a positive decision, doubt we will be worrying about Nov puts. Here’s one of my optimistic thoughts…. not sure why the FDA would have bothered to complete the facility check - required for approval, if they had approval issues in general but only the FDA knows.
|
|
|
|
Post by lakon on Sept 21, 2021 5:48:35 GMT -5
It’s all riding on the FDA‘s decision sometime between now and the end of Oct. I am still thinking Oct 15 at the latest but just my guess. If it is a positive decision, doubt we will be worrying about Nov puts. Here’s one of my optimistic thoughts…. not sure why the FDA would have bothered to complete the facility check - required for approval, if they had approval issues in general but only the FDA knows. Are the departments independent? They should be. Does the FDA like to head fake? |
|
|
|
Post by prcgorman2 on Sept 21, 2021 6:21:24 GMT -5
I agree although I would say revenue from Afrezza has been surprisingly consistent, and of material importance. Even with COVID preventing in-person sales, Afrezza revenues were substantive and steady, although obviously still not profitable yet. (I didn’t bother looking at the income statement but I assume 2020 revenue from Afrezza was around $70M and that we’ll be near that number again this year.) The 10K for 2020 shows that Afrezza net revenue for 2020 was $32.324 M. investors.mannkindcorp.com/static-files/c200a41e-04e9-4e86-a7d7-c74d7d1e237fThank you Clement. I appreciate the pointer. In a quick look at the income statement I didn’t see a number for total revenue and I was basing my guess of ~70M on the weekly Symphony numbers which had been showing around $1.1 or $1.2M per week for a long time. Regardless, net revenue is a better measure and I will only say I expect net revenue from Afrezza to be about the same again this year. |
|
|
|
Post by stockwhisperer on Sept 21, 2021 7:20:37 GMT -5
It’s all riding on the FDA‘s decision sometime between now and the end of Oct. I am still thinking Oct 15 at the latest but just my guess. If it is a positive decision, doubt we will be worrying about Nov puts. Here’s one of my optimistic thoughts…. not sure why the FDA would have bothered to complete the facility check - required for approval, if they had approval issues in general but only the FDA knows. Are the departments independent? They should be. Does the FDA like to head fake? No idea. Just seems that the time & cost for the facility inspection makes no sense if there were drug issues that would result in delays or no approval. Kinda seems like putting the cart before the horse. Can not find anything about the order in which the FDA does these things - maybe simultaneously. It’s all a secret until the great reveal. In any case - all opinions & speculations. Charts will react to sentiment. Would guess, like most anticipated FDA decisions - the sp will start moving up some, soon. |
|
|
|
Post by dh4mizzou on Sept 21, 2021 7:40:07 GMT -5
stockwhisperer,
If there is anything I've learned it's that wasting money and effort is not uncommon with our governmental agencies.
|
|
|
|
Post by anderson on Sept 21, 2021 8:25:35 GMT -5
Are the departments independent? They should be. Does the FDA like to head fake? No idea. Just seems that the time & cost for the facility inspection makes no sense if there were drug issues that would result in delays or no approval. Kinda seems like putting the cart before the horse. Can not find anything about the order in which the FDA does these things - maybe simultaneously. It’s all a secret until the great reveal. In any case - all opinions & speculations. Charts will react to sentiment. Would guess, like most anticipated FDA decisions - the sp will start moving up some, soon. You must have missed it when listening to the webcasts. The inspection was not only for Tyvaso dpi but a periodic inspection of the plant(ie for Afrezza as well) and is why it took so long. Last inspection was when Afrezza was getting approval so they were overdue. |
|
|
|
Post by celo on Sept 21, 2021 9:14:35 GMT -5
Stock price is definitely in wait and see what the FDA does mode. Flag comes to a point around Thanksgiving. Sometime soon it will break north or south.
|
|
